A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia

    December 2012 in “http://isrctn.org/>
    Evelyne Guénolé

    We don't know much about this study yet.

    We're trying to become the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    View this study on isrctn.com →